BlackRock Health Sciences Opportunities Portfolio Investor C Shares (SHSCX)

Fund Assets	6.26B
Expense Ratio	1.865%
Min. Investment	$1,000
Turnover	49.00%
Dividend (ttm)	n/a
Dividend Yield	n/a
Dividend Growth	n/a
Payout Frequency	Semi-Annual
Ex-Dividend Date	Jul 22, 2026

Previous Close	48.16
YTD Return	10.03%
1-Year Return	19.66%
5-Year Return	32.92%
52-Week Low	45.14
52-Week High	54.27
Beta (5Y)	0.69
Holdings	142
Inception Date	Oct 16, 2000

About SHSCX

This fund commits a minimum of 80% of its total capital to equity investments, primarily common stocks, issued by companies active in the health sciences and related industries. This scope includes, but is not limited to, businesses specializing in medical equipment and supplies, healthcare provision and services, biotechnology, and pharmaceuticals. A substantial portion of its portfolio, exceeding 25% of its assets, will be concentrated within these health sciences or associated sectors. Furthermore, the fund has the discretion to invest in companies based in non-U.S. countries.

• Fund Family: BlackRock
• Category: Health
• Performance Rating: Above Average
• Risk Rating: Low
• Stock Exchange: Nasdaq
• Ticker Symbol: SHSCX
• Share Class: Investor C
• Index: Russell 3000 Healthcare TR

Performance

SHSCX had a total return of 19.66% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.17%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

Symbol	Share Class	Expense Ratio
SHSSX	Institutional	0.86%
SHSAX	Investor A	1.11%
SHISX	Service	1.16%

Top 10 Holdings

53.34% of assets

Name	Symbol	Weight
Eli Lilly and Company	LLY	11.92%
Johnson & Johnson	JNJ	8.03%
Merck & Co., Inc.	MRK	5.56%
AbbVie Inc.	ABBV	5.07%
Thermo Fisher Scientific Inc.	TMO	4.41%
UnitedHealth Group Incorporated	UNH	4.33%
Gilead Sciences, Inc.	GILD	4.09%
Amgen Inc.	AMGN	3.98%
Vertex Pharmaceuticals Incorporated	VRTX	3.33%
Abbott Laboratories	ABT	2.61%

Dividend History

Ex-Dividend	Amount	Pay Date
Jul 22, 2026	$6.46449	Jul 23, 2026
Dec 9, 2025	$2.85576	Dec 10, 2025
Jul 17, 2025	$3.83665	Jul 18, 2025
Dec 11, 2024	$3.09215	Dec 12, 2024
Jul 18, 2024	$2.49135	Jul 19, 2024
Dec 7, 2023	$0.99992	Dec 8, 2023

Data Sources: Tiingo, Financial Modeling Prep, and more

Historical data is provided by Tiingo. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Oct 16, 2026

Data Sources Report a data error